Cargando…
Review time of oncology drugs and its underlying factors: an exploration in China
Introduction: How the launch delay of drugs and other factors of interest can influence the length of the review period by drug agencies is still unknown, and understanding this can help better strike the trade-off related to review speed. Methods: We included all new oncology drug applications subm...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10654631/ https://www.ncbi.nlm.nih.gov/pubmed/38027001 http://dx.doi.org/10.3389/fphar.2023.1151784 |